Urgent.News

What's breaking now, across thousands of outlets.

Science

Sanofi taps new startup ScionxBio for long-acting RNA

ScionxBio has inked a deal with French drugmaker Sanofi — its first partnership since splitting from parent company Eleven Therapeutics a few months ago. Under the agreement, ScionxBio will screen Sanofi’s mRNA candidates through its so-called ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Science

More from Monday 19 October →